Geode Capital Management
TTNP

Geode Capital Management’s Titan Pharmaceuticals TTNP Stock Holding History

Geode Capital Management’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,397
Closed -$29K – 4637
2023
Q4 		$29K Hold
4,397
– – ﹤0.01% 4455
2023
Q3 		$40.9K Buy
4,397
+1,199
+37% +$12.8K ﹤0.01% 4465
2023
Q2 		$41.4K Hold
3,198
– – ﹤0.01% 4543
2023
Q1 		$53K Hold
3,198
– – ﹤0.01% 4503
2022
Q4 		$50K Sell
3,198
-7
-0.2% -$132 ﹤0.01% 4591
2022
Q3 		$69K Buy
3,205
+87
+3% +$2.25K ﹤0.01% 4697
2022
Q2 		$34K Buy
3,118
+465
+18% +$5.8K ﹤0.01% 4856
2022
Q1 		$50K Hold
2,653
– – ﹤0.01% 4803
2021
Q4 		$54K Sell
2,653
-2
-0.1% -$60 ﹤0.01% 4845
2021
Q3 		$99K Hold
2,655
– – ﹤0.01% 4679
2021
Q2 		$138K Buy
2,655
+879
+49% +$44K ﹤0.01% 4470
2021
Q1 		$105K Hold
1,776
– – ﹤0.01% 4289
2020
Q4 		$116K Buy
1,776
+916
+107% +$72.4K ﹤0.01% 4027
2020
Q3 		$85K Hold
860
– – ﹤0.01% 3932
2020
Q2 		$158K Buy
860
+121
+16% +$20.8K ﹤0.01% 3724
2020
Q1 		$103K Buy
739
+601
+436% +$93.9K ﹤0.01% 3759
2019
Q4 		$16K Hold
138
– – ﹤0.01% 4174
2019
Q3 		$22K Hold
138
– – ﹤0.01% 4140
2019
Q2 		$105K Buy
138
+43
+45% +$39.3K ﹤0.01% 3950
2019
Q1 		$101K Hold
95
– – ﹤0.01% 3895
2018
Q4 		$76K Buy
95
+68
+252% +$76.2K ﹤0.01% 3912
2018
Q3 		$19K Hold
27
– – ﹤0.01% 4097
2018
Q2 		$104K Buy
27
+3
+13% +$10K ﹤0.01% 3859
2018
Q1 		$91K Hold
24
– – ﹤0.01% 3866
2017
Q4 		$115K Hold
24
– – ﹤0.01% 3787
2017
Q3 		$152K Hold
24
– – ﹤0.01% 3732
2017
Q2 		$165K Sell
24
-10
-29% -$93K ﹤0.01% 3743
2017
Q1 		$402K Hold
34
– – ﹤0.01% 3389
2016
Q4 		$487K Buy
34
+3
+10% +$50.5K ﹤0.01% 3272
2016
Q3 		$666K Buy
31
+1
+3% +$19.4K ﹤0.01% 3136
2016
Q2 		$595K Buy
30
+9
+43% +$192K ﹤0.01% 3151
2016
Q1 		$364 Hold
21
– – ﹤0.01% 3390
2015
Q4 		$337K Buy
+21
New +$342K ﹤0.01% 3457

Other funds holding TTNP

Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GWSA
Global Wealth Strategies & Associates Denver, Colorado $528M AUM 23.18% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

Geode Capital Management's TTNP Position: Q1 2024 in Review

Geode Capital Management sold out of Titan Pharmaceuticals (TTNP) in Q1 2024, closing a stake of 4,397 shares — an estimated $29K sold.

Geode Capital Management first reported a position in TTNP in Q4 2015 and held it in 33 quarters. The position peaked at $666K in Q3 2016. 17 funds tracked by Wall St. Rank hold TTNP as of Q1 2024.

  • Geode Capital Management reported no remaining Titan Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Geode Capital Management sold 4,397 Titan Pharmaceuticals shares in Q1 2024, an estimated $29K.
  • Geode Capital Management first reported a position in Titan Pharmaceuticals in Q4 2015 and held it in 33 quarters.
  • Geode Capital Management's Titan Pharmaceuticals position peaked at $666K in Q3 2016.
  • 17 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q1 2024.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.